Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction:the continuing controversy

This publication has 50 references indexed in Scilit:

• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications
  American Heart Journal, 1979
• The clinical pharmacology of beta-adrenoceptor-blocking drugs
  Progress in Cardiovascular Diseases, 1976
• Long-term propranolol therapy for angina pectoris
  The American Journal of Cardiology, 1976
• Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral Propranolol
  Circulation, 1974
• The role of β-adrenergic blockade in myocardial infarction
  Progress in Cardiovascular Diseases, 1974
• Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.
  Heart, 1971
• Effect of Ischemia and Antianginal Drugs on the Distribution of Radioactive Microspheres in the Canine Left Ventricle
  Circulation Research, 1971
• Hemodynamic Effects of Nitroglycerin, Propranolol, and Their Combination in Coronary Heart Disease
  Circulation, 1969
• Effect of Therapy on Survival in Angina Pectoris.
  Annals of Internal Medicine, 1968
• Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man.
  Journal of Clinical Investigation, 1965